论文部分内容阅读
目的:了解临床上应用丹红注射液的具体情况,为规范丹红注射液的临床应用提供参考。方法:采用集中监测法选取本院2010年3月-2012年2月使用丹红注射液的住院患者,从用药开始至用药结束15 d进行全程跟踪,填写评价筛选表,进行统计分析。结果:所有使用丹红注射液的住院患者中,54.69%的患者主要诊断或其他诊断符合丹红注射液说明书上的适应证;用药剂量超过说明书规定的范围的占8.2%;用药疗程过长或过短占10.35%和27.34%;选用溶媒不当的占13.67%;不良反应发生率为0。结论:丹红注射液不良反应的发生率较低,临床使用中药注射液欠规范,应加强管理。
Objective: To understand the clinical application of Danhong injection specific circumstances, to provide a reference for the standard Danhong injection clinical application. Methods: The centralized monitoring method was used to select the hospitalized patients who used Danhong injection from March 2010 to February 2012 in our hospital. The patients were followed up for 15 days from the start of the treatment to the end of the treatment. The evaluation and selection form was filled in for statistical analysis. Results: Among all the inpatients who used Danhong injection, 54.69% of the patients had their main diagnosis or other diagnosis accorded with the indications in Danhong injection; the dosage exceeded the range specified in the instruction manual by 8.2%; the treatment course was too long or Too short accounted for 10.35% and 27.34%; improper use of solvent accounted for 13.67%; adverse reaction rate was 0. Conclusion: Danhong injection has a low incidence of adverse reactions, clinical use of Chinese medicine injection is not standardized, should be strengthened management.